Related Experiment Video

Updated: Feb 6, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

5.4K

[Research Progress on Diagnosis and Treatment of B Cell Chronic Lymphoproliferative Disease--Review]

Yue-Yang Li1, Dong-Zhi Hu2, Chen Tian3

  • 1Department of Hematology, Tianjin Medical University Cancer Hospital National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy; Tianjin 300060, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|August 17, 2018
PubMed

Insights

Recent advancements in targeted therapies offer new hope for patients with B cell chronic lymphoproliferative diseases (B-CLPD). This review highlights progress in diagnosing and treating these conditions, focusing on novel drugs impacting cell cycle and apoptosis.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • The 2016 World Health Organization (WHO) classification categorizes various B cell chronic lymphoproliferative diseases (B-CLPD).
  • These diseases share similarities in morphology, immunophenotype, and genetics but differ in prognosis and treatment.
  • Existing treatments for B-CLPD have limitations, necessitating exploration of novel therapeutic strategies.

Purpose of the Study:

  • To review recent progress in the diagnosis and treatment of B cell chronic lymphoproliferative diseases (B-CLPD).
  • To discuss the impact of novel targeted therapies on B-CLPD management.
  • To provide an overview of emerging drugs affecting cell cycle and apoptosis pathways in B-CLPD.

Main Methods:

  • Literature review of recent studies on B cell chronic lymphoproliferative diseases (B-CLPD).
  • Analysis of diagnostic advancements and therapeutic strategies.
  • Focus on novel drug classes including proteasome inhibitors, immune modulators, and histone deacetylase inhibitors.

Main Results:

  • New drugs targeting cell cycle and apoptosis pathways have shown encouraging results in B-CLPD.
  • Targeted therapies offer improved outcomes and new hope for patients with B-CLPD.
  • Significant progress has been made in understanding and managing various B-CLPD subtypes.

Conclusions:

  • Novel targeted therapies represent a significant advancement in the treatment of B cell chronic lymphoproliferative diseases (B-CLPD).
  • Continued research into drugs affecting cell cycle and apoptosis pathways is crucial for improving patient prognosis.
  • Recent diagnostic and therapeutic progress offers a more optimistic outlook for individuals with B-CLPD.

More Related Videos

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.6K
Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

1.1K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
963
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
740
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.6K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K